Our latest press releases, media appearances and news commentary.
Medicines Discovery Catapult has appointed Dr Robin Brown as its new Chairman.
CEO, Chris Molloy, was awarded Membership of the Institute of Cancer Research (ICR) at a ceremony in London.
CBSO, Mark Samuels, had a Letter to the Editor published in The Times.
Health Secretary Matt Hancock officially opened the biggest diagnostic lab network in British history.
CEO, Chris Molloy, discusses the role of Medicines Discovery Catapult within the UK as a centre for applied medical R&D.
Pharmaphorum’s Deep Dive magazine “Future Pharma” focuses on the predictions for healthcare and the drug development process.
Business Secretary Greg Clark launched the Rosalind Franklin Institute.
Business Secretary Greg Clark launched the Rosalind Franklin Institute.
CEO, Chris Molloy and our Precision Medicine Lead, James Peach, spoke to PharmaTimes.
Our Chief Informatics Officer, Professor John Overington, supports Prime Minister Theresa May’s plans to use AI as a weapon for fighting cancer.
See how we can help support you with your next drug discovery project.
Speak to us